| D008582 |
Meningitis, Aseptic |
A syndrome characterized by headache, neck stiffness, low grade fever, and CSF lymphocytic pleocytosis in the absence of an acute bacterial pathogen. Viral meningitis is the most frequent cause although MYCOPLASMA INFECTIONS; RICKETTSIA INFECTIONS; diagnostic or therapeutic procedures; NEOPLASTIC PROCESSES; septic perimeningeal foci; and other conditions may result in this syndrome. (From Adams et al., Principles of Neurology, 6th ed, p745) |
Aseptic Meningitis |
|
| D011239 |
Prednisolone |
A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. |
Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF |
|
| D002648 |
Child |
A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. |
Children |
|
| D003937 |
Diagnosis, Differential |
Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. |
Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis |
|
| D005260 |
Female |
|
Females |
|
| D005500 |
Follow-Up Studies |
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. |
Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup |
|
| D005938 |
Glucocorticoids |
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. |
Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000893 |
Anti-Inflammatory Agents |
Substances that reduce or suppress INFLAMMATION. |
Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents |
|
| D020042 |
Histiocytic Necrotizing Lymphadenitis |
Development of lesions in the lymph node characterized by infiltration of the cortex or paracortex by large collections of proliferating histiocytes and complete or, more often, incomplete necrosis of lymphoid tissue. |
Kikuchi Disease,Lymphadenitis, Histiocytic Necrotizing,Histiocytic Necrotising Lymphadenitis,Kikuchi Necrotizing Lymphadenitis,Kikuchi's Disease,Kikuchi-Fujimoto Disease,Kikuchi-Fujimoto's Disease,Nosocomial Kikuchi's Disease,Disease, Kikuchi,Disease, Kikuchi's,Disease, Kikuchi-Fujimoto,Disease, Kikuchi-Fujimoto's,Histiocytic Necrotising Lymphadenitides,Kikuchi Fujimoto Disease,Kikuchi Fujimoto's Disease,Kikuchi's Disease, Nosocomial,Kikuchi-Fujimotos Disease,Kikuchis Disease,Lymphadenitides, Histiocytic Necrotising,Lymphadenitis, Histiocytic Necrotising,Lymphadenitis, Kikuchi Necrotizing,Necrotising Lymphadenitides, Histiocytic,Necrotising Lymphadenitis, Histiocytic,Necrotizing Lymphadenitis, Histiocytic,Necrotizing Lymphadenitis, Kikuchi,Nosocomial Kikuchi Disease,Nosocomial Kikuchis Disease |
|